Companies / Financials
AFL
Aflac
Life & Health Insurance
Life & Health InsuranceAnalysis in progress
In progress
We are decoding this company's strategy and relationships
New analyses are published every weekday. Founding members get them first.
Business at a glance
Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work
Operating health64
Growth3
Profitability87
Cash generationn/a
Balance sheetn/a
Dilution control100
Key ratios and five-year financials
Latest quarter revenue YoY (2026-09-30)-31.0%Revenue growth (FY)-9.3%Revenue CAGR (3y)-3.6%Gross margin—Operating margin—Net margin21.2%Free cash flow margin14.9%R&D / revenue—Stock comp / revenue—Net debt / operating cash flow—Current ratio—Diluted share count change-5.3%
| Fiscal year ending | FY 2021-12 | FY 2022-12 | FY 2023-12 | FY 2024-12 | FY 2025-12 |
|---|---|---|---|---|---|
| Revenue | $21.6B | $19.1B | $18.7B | $18.9B | $17.2B |
| Operating income | $4.9B | $4.2B | — | — | — |
| Net income | $4.2B | $4.4B | $4.7B | $5.4B | $3.6B |
| Operating cash flow | $5.1B | $3.9B | $3.2B | $2.7B | $2.6B |
| Free cash flow | $5.1B | $3.9B | $3.2B | $2.7B | $2.6B |
| Buybacks | $2.3B | $2.4B | $2.8B | $2.8B | $3.5B |
| Dividends | $855M | $979M | $966M | $1.1B | $1.2B |
| Cash | $5.1B | $3.9B | $4.3B | $6.2B | $6.2B |
| Equity | $17.0B | $20.1B | $22.0B | $26.1B | $29.5B |
StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.